About CLOVER BIO-B Company

We are a global biopharmaceutical company dedicated to saving lives and improving global health with innovative vaccines. Since our establishment in 2007, we have relied on the Trimer-Tag technology platform to build our own R&D capabilities in Chengdu, Sichuan Province, China. We have also established a commercial production base in Changxing, Zhejiang Province, China, and formed a world-class team dedicated to our mission of using transformative science and global partnerships to bring innovative vaccines to the world for the benefit of more people. Today, with comprehensive R&D capabilities, production and commercialization capabilities, and strong partner relationships with relevant agencies distributed around the world, we have two authorized vaccines, namely the COVID-19 booster vaccine and the quadrivalent seasonal influenza vaccine. At the same time, we are also promoting a diverse pipeline of vaccine candidates, hoping that our vaccine can prevent more diseases and promote the reduction of the burden on public health. While we focus on providing vaccines for a healthier world, we remain steadfast in our commitment to scientific innovation and equity in vaccine supply.